Investing.com - Oramed reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Oramed announced earnings per share of $-0.18 on revenue of $682K. Analysts polled by Investing.com anticipated EPS of $-0.24 on revenue of $696.2K.
Oramed shares are down 53.92% from the beginning of the year, still down 77.50% from its 52 week high of $29.24 set on November 15, 2021.
Oramed follows other major Healthcare sector earnings this month
Oramed's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar